JENNIFER L GOOD
CIK 1229245 · President & CEO · last filed 2026-06-25
JENNIFER L GOOD is a President & CEO who has filed 49 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for RYTM, was dated Jun 25, 2026. Across all open-market trades the lifetime net is −$4.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.25M
4
49
-$4.45M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RYTM | Director | 11,712 | $105.87 | $1.24M | -$4.27M | 13 | 2026-06-25 |
| TRVI | President & CEO | 218,576 | $18.36 | $4.01M | -$195.5K | 19 | 2026-02-20 |
| JUNIPER PHARMACEUTICALS INC (JNP) Delisted | Director | 0 | — | — | $0 | 2 | 2018-08-15 |
| PENWEST PHARMACEUTICALS CO (PPCO) Delisted | President & CEO | 18,034 | — | — | $16.1K | 10 | 2010-09-22 |
Recent Filings
49 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-25 | RYTM | Mixed | +4,712 | $0 | EDGAR |
| 2026-02-20 | TRVI | Grant (A) | — | $0 | EDGAR |
| 2025-06-26 | RYTM | Grant (A) | — | $0 | EDGAR |
| 2025-06-23 | RYTM | Exer (M) | +4,000 | $0 | EDGAR |
| 2025-06-03 | TRVI | Grant (A) | — | $0 | EDGAR |
| 2025-03-25 | TRVI | Mixed | — | -$27.1K | EDGAR |
| 2025-03-21 | TRVI | Notice (144) | −5,263 | -$34.6K | EDGAR |
| 2025-03-12 | TRVI | Grant (A) | — | $0 | EDGAR |
| 2025-02-20 | TRVI | Grant (A) | — | $0 | EDGAR |
| 2024-09-19 | RYTM | Mixed | — | -$979.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.